Arvinas ARVN
NASDAQ ARVN
$6.91 -0.01 (-0.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Arvinas (ARVN) Shares Repurchased (2025)

Updated

Arvinas (ARVN) posted Shares Repurchased of $74.1 million for Q4 2025.

Analysis

Arvinas (ARVN) Shares Repurchased (2025) Analysis & Trends

For FY2025, Arvinas' Shares Repurchased came in at $91.9 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.71 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 653.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 370.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Arvinas 453.26 Mn -1.97 Bn 400,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 74.10 Mn
API Access

Arvinas Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=ARVN&period=max&api_key=YOUR_API_KEY